Dementia in Nursing HomeNCT07182019
Connecting Today to Combat Social Isolation and Loneliness
A study testing Connecting Today in people with Dementia in Nursing Home and Family, run by University of Alberta at 1 site in Canada.
Trial summary
The investigators developed Connecting Today, a feasible and highly acceptable remote visiting program that can support care home residents living with moderate to severe dementia to have video calls with their family members, friends, or care partners. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Dementia in Nursing Home, Family, Remote Visits
- What is being tested?
- Connecting Today
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 320 participants
- Where
- 1 siteCanada
- Study dates
- 9 Jun 2026to 30 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Residents:
- are at least 65 years old
- are diagnosed with any type of dementia
- have a Cognitive Performance Score (CPS) indicating moderate to severe impairment (CPS 3-6).
- to participate, residents must also have people that self identify as a family member or friend of the person with dementia.
- Remote visitors:
Show all 10Show fewer
- are people that self-identify as a family member or friend of the person with dementia
- are people with whom the person with dementia desires contact
- are 18 or older
- understand and speak English.
Who cannot join
- All remote visitors are required to understand and speak English as this is necessary for the facilitator to support the call and for data to be collected.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
University of Alberta
Edmonton, Alberta, T6G 2R3
Hannah O'Rourke, PhD, RN, hannah.orourke@ualberta.ca
Jenny Swindle, BA, MA, PhD, jswindle@ualberta.ca
About this study
Official title: Connecting Today to Combat Social Isolation and Loneliness: An Evaluation of a Remote Visiting Program for Care Home Residents Living With Dementia
The investigators developed Connecting Today, a feasible and highly acceptable remote visiting program that can support care home residents living with moderate to severe dementia to have video calls with their family members, friends, or care partners. The investigators will recruit 80 residents from 4 care homes, and their family members, friends, or care partners. All participants will be offered 60 minutes of Connecting Today per week for 6 weeks (in either the intervention group, or in the wait-list control group). An onsite care provider will be trained to tailor the video calls, and facilitate positive verbal and non-verbal engagement during the calls. The investigators will evaluate how Connecting Today affects outcomes for residents (quality of life, loneliness, and responsive behaviours) and their remote visitors (quality of life, loneliness, and social support). The investigators will assess how outcomes differ for men, women, and people with different perceptions and experiences of Connecting Today.
Read the detailed description
Justification For decades, care home residents living with dementia have suffered disproportionately from social isolation (being alone), loneliness (feeling alone), and poor quality of life. Paradoxically, they have also been excluded from intervention research to address these pernicious problems. The investigators developed Connecting Today, a facilitated remote visiting program, to engage care home residents with dementia in positive interactions with their family members, friends, and care partners. Scoping reviews, a mixed methods study, and pilot/ feasibility studies in Alberta support feasibility and high acceptability of Connecting Today.
Purpose This study will evaluate the feasibility of a multi-province RCT of Connecting Today in preparation for a full effectiveness trial.
Objectives
- Assess feasibility of a pragmatic randomized wait-list control trial of Connecting Today, a remote visiting program, when used in care homes in Alberta, Saskatchewan and Ontario.
- Examine Connecting Today's hypothesized mechanisms of action within intervention and wait-list control groups.
Research Method/Procedures The investigators will recruit 80 residents living with dementia from 4 total care homes (one each in Alberta, Saskatchewan, and two in Ontario) and their family members, friends, or care partners (1 to 3 for each resident). Participants will receive 6 weeks of Connecting Today: facilitated video calls (up to 60 min weekly). Residents' designated decision-makers will provide consent for resident participation. Research assistants (blinded to assignment status) will collect reliable and valid outcome measures in telephone interviews for residents (via proxy report) and remote visitors (via self-report). Outcomes are measured for all participants at: T0=baseline (weeks 1-2), T1=after 6 weeks of intervention delivery to the treatment group (weeks 9-10), and T2=after 6 weeks of intervention delivery to the control group (weeks 17-18).
The difference between the control group and intervention group is timing of intervention delivery. The intervention group will receive the intervention in weeks 3-8 (i.e. between T0 and T1) and the control group will receive the intervention in weeks 11-16 (i.e. between T1 and T2).
Plan for Data Analysis To address aim 1 (feasibility), the investigators will complete a quantitative assessment of trial and intervention processes including rates of recruitment, retention, attrition, fidelity of intervention delivery, and missing data (compared to pre-specified thresholds), assignment beliefs, treatment experiences and perceptions, and features of usual care.
To address aim 2 (mechanisms of action), the investigators will use generalized estimating equations and a single group before-after design combining intervention and wait-list control groups to complete a within-group outcomes analysis, adjusted for care home cluster and with gender and intervention processes included as covariates/moderators.
- Conditions
- Dementia in Nursing Home, Family, Remote Visits
- Being tested
- Connecting Today
- Keywords
- Quality of life, Loneliness, Social support
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Connecting TodayBehavioural
Connecting today is a facilitated remote visiting program for people living with moderate to severe dementia in care homes. The program offers residents up to 60 minutes of scheduled contact with a family member, friend or volunteer by video call. An onsite facilitator supports the video calls which are delivered via ipad/zoom.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | The intervention group will receive the Connecting Today intervention for 6 weeks following T0 (i.e. the first outcome data collection period). Receives: Behavioral: Connecting Today |
| Control | No intervention | The control group will not receive the Connecting Today intervention after T0. They are a waitlist control, so will receive the Connecting Today intervention after T1 (i.e. after the second outcome data collection period). Data collection for outcome variables will be the same as participants in the intervention group. The only difference between groups is timing of the intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in the Dementia Quality of Life Instrument (DEMQOL- proxy) total score.
Resident quality of life will be measured with the Dementia Quality of Life Instrument (DEMQOL- proxy) total score (completed by a family/friend who knows the person living with dementia well). A sum of 31 items (rated on a 4-point scale) generates the total score, where 31 is the worst possible quality of life and 124 is the best possible quality of life. Items relate to how the person living with dementia feels about their daily activities, health and well-being, cognitive functioning, social relationships, and self-concept.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH) total score.
The Dementia Quality of Life - Care Home instrument (DEMQOL-CH) is a quality of life assessment tool for people living with dementia that is completed by care home staff (i.e. research nurse). There are 31 items rated on a 4-point scale (total score 31-124), where 31 is the worst possible quality of life and 124 is the best possible quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the the Quality of Life - Aged Care Consumers (QOL-ACC- proxy) total score.
Resident quality of life will be measured using the Quality of Life - Aged Care Consumers (QOL-ACC-proxy). It is completed by someone who knows the resident well (in this study both a family/friend proxy and research nurse will complete the measure), and includes questions on health-related and psychosocial aspects of quality of life. There are 6 questions that are answered on a 5 point scale. Total scores range from 0 to 24, with higher scores indicating better quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Secondary outcomes (11)
Change in single item from the Dementia Quality of Life Instrument (DEMQOL- proxy)
Resident global quality of life will be measured with a single item from the Dementia Quality of Life Instrument (DEMQOL- proxy) completed by a family/friend who knows the person living with dementia well. The single item rates quality of life overall, and is rated on a 4-point scale (total score 1-4), where higher scores indicate higher quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in a single item from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH)
Resident global quality of life will be measured with a single item from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH) completed by care home staff (i.e. research nurse) who knows the person living with dementia well. The single item rates quality of life overall and is rated on a 4-point scale (total score 1-4), where higher scores indicate higher quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in three items from the Dementia Quality of Life Instrument (DEMQOL- proxy)
Resident loneliness will be measured with three items from the Dementia Quality of Life Instrument (DEMQOL- proxy) (completed by a family/friend who knows the person living with dementia well). These include worries about: (1) getting in touch with people; (2) not having enough company; (3) not being able to help other people. Each item is rated on a 4-point scale (total score 1-4), with higher scores indicating less loneliness. Each will be analyzed as single items.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in three items from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH)
Resident loneliness will be measured with three items from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH) completed by care home staff (i.e. research nurse) who knows the person living with dementia well. These include worries about: (1) getting in touch with people; (2) not having enough company; (3) not being able to help other people. Each item is rated on a 4-point scale (total score 1-4), with higher scores indicating less loneliness. Each will be analyzed as single items.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Social Connection In Long-Term Care Home Residents (SONNET) Scale-proxy
Change in resident loneliness will be measured by the Social Connection In Long-Term Care Home Residents (SONNET) Scale-proxy, completed by a research nurse. This scale measures overall social connection of residents, as well as their social engagement and social connectedness. There are 12 questions rated on a 4 point scale (total score 0-36), with higher scores indicating higher social connection.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Cohen-Mansfield Agitation Inventory - short form
Resident responsive behaviours will be measured using the Cohen-Mansfield Agitation Inventory - short form, and will be completed by a research nurse. This measures the occurrence of 14 resident behaviours in the last 2 weeks (5-point scales). Three factors are calculated (aggressive behavior, physically non-aggressive behavior, and verbally agitated behavior). Scores range from 14 to 70 with higher scores indicating more frequent agitated behaviors.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the 3-item Loneliness Scale total score
Remote visitor loneliness will be measured using the 3-item Loneliness Scale total score, which is self-reported. Perceptions of companionship are assessed with three items (3-point scale). Scores range from 3 to 9 (higher scores indicate more loneliness).
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Multidimensional Scale of Perceived Social Support (MSPSS) total score
Remote visitor social support will be measured using the Multidimensional Scale of Perceived Social Support (MSPSS) total score. The MSPSS is comprised of a total of 12 items (on 7 point scales), with 4 items for each subscale (reflecting social support from significant others, family, and friends). The total score is an average, calculated by summing all items (which could range from 12 to 84) and dividing by 12 (higher scores indicate more social support).
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Quality of Life Scale (QOLS)
Remote visitor quality of life will be measured by the Quality of Life Scale (QOLS). This scale includes 16 items (scored on a 7 point scale), with possible scores ranging from 16-112. Higher scores indicate higher quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Satisfaction with Life Scale (SWLS)
Remote visitor quality of life will be measured by the Satisfaction with Life Scale (SWLS). This will be self-reported, and includes 5 questions on 7 point scales (total score 5-35). Higher scores indicated higher life satisfaction.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in a single item from the World Health Organization Quality of Life (WHOQOL- BREF)
Remote visitor quality of life will be measured by a single item from the World Health Organization Quality of Life (WHOQOL- BREF). This will be self-reported, and includes responding on a 5 point scale (total score 1-5). The higher the score, the higher the quality of life.
Measured: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2025
- Study start9 Jun 2026
- Primary completion30 Sep 2026 (estimated)
- Study completion30 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dementia in Nursing HomeStudies of the same condition, open and under way.
- More trials run by University of AlbertaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 320 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Responsible party
- Sponsor
- Investigators
- Hannah O'Rourke, PhD, Principal investigator, University of AlbertaMatthias Hoben, Dr rer medic, Principal investigator, York UniversityShelley Peacock, PhD, Principal investigator, University of Saskatchewan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07182019
- Sponsor's protocol ID
- Pro00152323
- Status last verified
- Jun 2026
- First submitted
- 16 Sep 2025
- Last updated
- 1 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Connecting Today to Combat Social Isolation and Loneliness: An Evaluation of a Remote Visiting Program for Care Home Residents Living With Dementia
- ClinicalTrials.gov ID
- NCT07182019
- Acronym / sponsor ID
- Pro00152323
- Conditions
- Dementia in Nursing Home, Family, Remote Visits
- Keywords
- Quality of life, Loneliness, Social support
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 320 participants (estimated)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR)
- Study start
- 9 Jun 2026 (actual)
- Primary completion
- 30 Sep 2026 (estimated)
- Study completion
- 30 Sep 2026 (estimated)
- First posted
- 19 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators developed Connecting Today, a feasible and highly acceptable remote visiting program that can support care home residents living with moderate to severe dementia to have video calls with their family members, friends, or care partners. The investigators will recruit 80 residents from 4 care homes, and their family members, friends, or care partners. All participants will be offered 60 minutes of Connecting Today per week for 6 weeks (in either the intervention group, or in the wait-list control group). An onsite care provider will be trained to tailor the video calls, and facilitate positive verbal and non-verbal engagement during the calls. The investigators will evaluate how Connecting Today affects outcomes for residents (quality of life, loneliness, and responsive behaviours) and their remote visitors (quality of life, loneliness, and social support). The investigators will assess how outcomes differ for men, women, and people with different perceptions and experiences of Connecting Today.
Detailed description
Justification For decades, care home residents living with dementia have suffered disproportionately from social isolation (being alone), loneliness (feeling alone), and poor quality of life. Paradoxically, they have also been excluded from intervention research to address these pernicious problems. The investigators developed Connecting Today, a facilitated remote visiting program, to engage care home residents with dementia in positive interactions with their family members, friends, and care partners. Scoping reviews, a mixed methods study, and pilot/ feasibility studies in Alberta support feasibility and high acceptability of Connecting Today.
Purpose This study will evaluate the feasibility of a multi-province RCT of Connecting Today in preparation for a full effectiveness trial.
Objectives
- Assess feasibility of a pragmatic randomized wait-list control trial of Connecting Today, a remote visiting program, when used in care homes in Alberta, Saskatchewan and Ontario.
- Examine Connecting Today's hypothesized mechanisms of action within intervention and wait-list control groups.
Research Method/Procedures The investigators will recruit 80 residents living with dementia from 4 total care homes (one each in Alberta, Saskatchewan, and two in Ontario) and their family members, friends, or care partners (1 to 3 for each resident). Participants will receive 6 weeks of Connecting Today: facilitated video calls (up to 60 min weekly). Residents' designated decision-makers will provide consent for resident participation. Research assistants (blinded to assignment status) will collect reliable and valid outcome measures in telephone interviews for residents (via proxy report) and remote visitors (via self-report). Outcomes are measured for all participants at: T0=baseline (weeks 1-2), T1=after 6 weeks of intervention delivery to the treatment group (weeks 9-10), and T2=after 6 weeks of intervention delivery to the control group (weeks 17-18).
The difference between the control group and intervention group is timing of intervention delivery. The intervention group will receive the intervention in weeks 3-8 (i.e. between T0 and T1) and the control group will receive the intervention in weeks 11-16 (i.e. between T1 and T2).
Plan for Data Analysis To address aim 1 (feasibility), the investigators will complete a quantitative assessment of trial and intervention processes including rates of recruitment, retention, attrition, fidelity of intervention delivery, and missing data (compared to pre-specified thresholds), assignment beliefs, treatment experiences and perceptions, and features of usual care.
To address aim 2 (mechanisms of action), the investigators will use generalized estimating equations and a single group before-after design combining intervention and wait-list control groups to complete a within-group outcomes analysis, adjusted for care home cluster and with gender and intervention processes included as covariates/moderators.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: Connecting TodayThe intervention group will receive the Connecting Today intervention for 6 weeks following T0 (i.e. the first outcome data collection period). |
| Control | No intervention | –The control group will not receive the Connecting Today intervention after T0. They are a waitlist control, so will receive the Connecting Today intervention after T1 (i.e. after the second outcome data collection period). Data collection for outcome variables will be the same as participants in the intervention group. The only difference between groups is timing of the intervention. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (10 listed)
- are at least 65 years old
- are diagnosed with any type of dementia
- have a Cognitive Performance Score (CPS) indicating moderate to severe impairment (CPS 3-6).
- to participate, residents must also have people that self identify as a family member or friend of the person with dementia.
- are people that self-identify as a family member or friend of the person with dementia
Key exclusion criteria (1 listed)
- All remote visitors are required to understand and speak English as this is necessary for the facilitator to support the call and for data to be collected.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Connecting TodayConnecting today is a facilitated remote visiting program for people living with moderate to severe dementia in care homes. The program offers residents up to 60 minutes of scheduled contact with a family member, friend or volunteer by video call. An onsite facilitator supports the video calls which are delivered via ipad/zoom. | Behavioural | Intervention |
Primary outcome
Change in the Dementia Quality of Life Instrument (DEMQOL- proxy) total score.
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Resident quality of life will be measured with the Dementia Quality of Life Instrument (DEMQOL- proxy) total score (completed by a family/friend who knows the person living with dementia well). A sum of 31 items (rated on a 4-point scale) generates the total score, where 31 is the worst possible quality of life and 124 is the best possible quality of life. Items relate to how the person living with dementia feels about their daily activities, health and well-being, cognitive functioning, social relationships, and self-concept.
Change in the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH) total score.
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
The Dementia Quality of Life - Care Home instrument (DEMQOL-CH) is a quality of life assessment tool for people living with dementia that is completed by care home staff (i.e. research nurse). There are 31 items rated on a 4-point scale (total score 31-124), where 31 is the worst possible quality of life and 124 is the best possible quality of life.
Change in the the Quality of Life - Aged Care Consumers (QOL-ACC- proxy) total score.
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Resident quality of life will be measured using the Quality of Life - Aged Care Consumers (QOL-ACC-proxy). It is completed by someone who knows the resident well (in this study both a family/friend proxy and research nurse will complete the measure), and includes questions on health-related and psychosocial aspects of quality of life. There are 6 questions that are answered on a 5 point scale. Total scores range from 0 to 24, with higher scores indicating better quality of life.
11 secondary outcomes
Change in single item from the Dementia Quality of Life Instrument (DEMQOL- proxy)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in a single item from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in three items from the Dementia Quality of Life Instrument (DEMQOL- proxy)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in three items from the Dementia Quality of Life - Care Home Instrument (DEMQOL- CH)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Social Connection In Long-Term Care Home Residents (SONNET) Scale-proxy
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Cohen-Mansfield Agitation Inventory - short form
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the 3-item Loneliness Scale total score
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Multidimensional Scale of Perceived Social Support (MSPSS) total score
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Quality of Life Scale (QOLS)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in the Satisfaction with Life Scale (SWLS)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Change in a single item from the World Health Organization Quality of Life (WHOQOL- BREF)
Time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Dementia in Nursing Home
Enrolling by invitationObservational study
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
Dementia
Enrolling by invitation
Preventing Loss of Independence Through Exercise in Community Living Centers
Dementia, Cognitive Dysfunction
Enrolling by invitationObservational study
Decoding Death and Dying in People With Dementia by Digital Thanotyping
Dementia
Recruiting
Protocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive Disorders
Dementia, Cognitive Dysfunction
Not yet recruiting
SENS'REM - SENSoriality and Multi-Sensory Emotional Reminiscences: a Pilot Study
Apathy, Apathy in Dementia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Hannah O'Rourke, PhD principal investigator
University of Alberta
Matthias Hoben, Dr rer medic principal investigator
York University
Shelley Peacock, PhD principal investigator
University of Saskatchewan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Connecting Today in people with Dementia in Nursing Home and Family, run by University of Alberta at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hannah O'Rourke, PhD (780-492-7961, hannah.orourke@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in the Dementia Quality of Life Instrument (DEMQOL- proxy) total score. (time frame: Baseline (T0), after 6 weeks of intervention delivery to the treatment group (T1), and after 6 weeks of intervention delivery to the control group (T2).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.